EMBL Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 9
Professionals
  • Investments
  • 44
  • Portfolio
  • 8
  • Exits
  • 23
Exits

EMBL Ventures General Information

Description

Founded in 2001, EMBL Ventures is a venture capital firm that seeks to invest in the biotechnology, medical technology and life-science sectors. The firm is based in Heidelberg, Germany.

Contact Information

Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Boxbergring 107
  • 69126 Heidelberg
  • Germany
+49 06221 000000

EMBL Ventures Investments (44)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Topas Therapeutics 29-Jul-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 000000 0000 00.0
0000 0000000 01-Apr-2019 00000 00000 Other Devices and Supplies Generating Revenue
000000000 00000000 30-Apr-2018 00000 00000 000.00 Drug Discovery Profitable 00000 0000 00.0
0000000 0000000000 04-Dec-2017 00000 00000 000.00 Drug Discovery Generating Revenue
00000 000000000000 02-Nov-2017 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 000 00000 00.0
000000000 00000000 26-Jun-2017 00000 00000 000.00 Biotechnology Generating Revenue
0000000 05-May-2017 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable 000 00000 00.0
0000000 12-Jan-2017 00000 00000 00.000 Diagnostic Equipment Generating Revenue 000000 0000 00.0
ViraTherapeutics 28-Oct-2016 Early Stage VC 00.000 Drug Discovery Generating Revenue
ImevaX 27-Sep-2016 Early Stage VC 00.000 Drug Discovery Clinical Trials - Phase 1 000000 0000 00.0
You’re viewing 10 of 44 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EMBL Ventures Exits (23)

Company Name Exit Date Exit Type Exit Size
Nirlus 01-Apr-2021 Secondary Transaction - Private
00000000 00000000 15-Mar-2021 000000000000000000 00000
00000 000000000000 01-Nov-2019 000 00 00000000
000000 00000000000 13-Jan-2019 0000000000: 000000
0000000000000000 13-Sep-2018 000000000000000000 00000
0000000 16-Nov-2017 000 0000
0000000 09-Nov-2017 000 00000
00000000000 31-May-2017 000000000000000000
Luxendo 05-May-2017 Merger/Acquisition 000.00
Jiff 03-Apr-2017 Merger/Acquisition
You’re viewing 10 of 23 exits. Get the full list »

EMBL Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore EMBL Ventures‘s full profile, request access.

Request a free trial

EMBL Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

EMBL Ventures Team (13)

Name Title Deals Funds Boards Office
Frank Mühlenbeck Managing Director Heidelberg, Germany
Heinz Schwer Ph.D Managing Director Heidelberg, Germany
Klaus Schollmeier Ph.D Venture Partner 0 Heidelberg, Germany
Rainer Wessel Ph.D Venture Partner Heidelberg, Germany
George Rehm JD Partner 0 0 0 Heidelberg, Germany
You’re viewing 5 of 13 team members. Get the full list »

EMBL Ventures Co-Investors (28)

Name With Exits Lead Partner Series Industry
BioMedPartners 2 0 Series chart Industry bar
Andera Partners 0 0 Series chart Industry bar
Forbion 0 0 Series chart Industry bar
Gimv 0 0 Series chart Industry bar
IP Group 0 0 Series chart Industry bar
You’re viewing 5 of 28 co-investors. Get the full list »